Public versus private cell therapy and stem cell companies
Cell therapy and RegenMed industry has a great variety of public and private companies. Currently, the overall value of public companies is much lower then private. If we look at cell therapy field,...
View ArticleOsiris boom and definition of stem cell product
Today US-based “stem cell therapeutic” company Osiris released a data from clinical trial, which assess their product Grafix in diabetic leg wounds. It was the biggest shake in the “stem cell...
View ArticleBig Pharma acquires stem cell, RegenMed and cell therapy assets
While ago, I’ve written about relationships between Pharma/ Biotech and cell therapy industry. Few years back, Pharma still was curious and “sniffing air” around, but what about now? This year, I’ve...
View Article10 new companies to watch
I’ve decided to do an experiment and overview some new companies that I like. If you like the idea, I can do it 1-2 times per year. You can suggest new cool companies to me. In order to pick companies...
View ArticleRegenMed, stem cell and cell therapy industry in 2013
At the end of the year, I overview the most interesting and important events in stem cell/ RegenMed/ cell therapy industry. This year I’d like to focus on trends, rather than separate events. Here is...
View ArticleCell therapy industry – expectations for 2014
Today, I’d like to highlight few trends and events, which will or could happen this year in cell therapy industry field. I don’t like to predict, so, I’d rather list some expectations. The field is...
View Article10 new companies to watch – part 2
5 months ago I’ve picked and brought to your attention a list of new interesting companies. In the last few months, I’ve learned more companies, and today, I’m sharing the new list of 10 with you. As...
View ArticleStem cell therapeutic products on the market – update 2
I continue to monitor “stem cell therapeutic products” on a market worldwide. These products could be approved by regulatory agencies or claimed (by manufacturers) as “tissue products” without...
View ArticleClik here to view.
RegenMed, stem cell and cell therapy industry in 2014
This is my annual overview the most interesting and important events in stem cell/ RegenMed/ cell therapy industry. It was very very eventful year! So, it was hard to pick “top 10″ and I combined some...
View ArticleCell/ gene therapy industry 2016 – expectations for market approvals
Last 3 years were not very successful for approvals of cell/ gene therapy products on the market. From zero (in 2014) to three (in 2013 and 2015) product approvals per year – very typical for the...
View Article
